At UT MD Anderson, we work in partnership with our patients to enable groundbreaking research to better prevent, diagnose and treat cancer. Grounded in a culture of collaboration, connectivity and data-based science, our research yields transformative findings that are shifting patient care and improving patients’ lives across the globe.
At the ASCO® Annual Meeting, our experts will showcase their pacesetting research and join colleagues for discussion on the latest advances in oncology.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open positions at UT MD Anderson.
Featured Article
Featured Podcast
Facing side effects: Supportive care for head and neck cancer patients
Patients with head and neck cancer often face challenging treatment side effects that can impact speaking, swallowing, taste and nutrition. These changes can affect everyday life and emotional well-being. Kate Hutcheson, Ph.D., and Clifton David Fuller, M.D., Ph.D., discuss how personalized supportive care can help preserve function and improve quality of life. Learn more about this episode and other podcast episodes
Meet the Experts
Visit UT MD Anderson to network with us, to ask a question, to learn about training and career opportunities and to continue the conversation on key presentations with our experts. A schedule will be available soon.
Our research by the numbers
$1.3B
invested in research
140
patents awarded to UT MD Anderson in FY25
1,579
clinical trials in FY25
Education and Training at UT MD Anderson
UT MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
The UT MD Anderson Radiation Quality Assurance Laboratory
The UT MD Anderson Radiation Quality Assurance Laboratory (RQA Lab) is a specialized service designed to meet the needs of the great oncology community by ensuring accurate radiation measurements in clinical trials. Our expert team offers a wide range of radiation physics services, including anthropomorphic phantom tests, virtual and onsite audits, contract services and clinical trial quality assurance.
Institutes at UT MD Anderson
United by a shared mission to end cancer, UT MD Anderson clinicians and scientists work seamlessly together to advance groundbreaking research that can transform the field of hematology. Leveraging our unique research ecosystem, including three leading institutes, we are pioneering new prevention, diagnostic and treatment approaches to address the most pressing needs for patients with cancer.
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Building upon unparalleled expertise, the Institute for Cell Therapy Discovery & Innovation is leading the world in developing and advancing impactful cell therapies for patients in need. By uniting the top minds in the field to lead exceptional fundamental, translational and clinical research, we're focused on creating breakthrough off-the-shelf therapies that can be readily adapted for both hematologic and solid tumors as well as devastating auto-immune conditions, infections and other diseases.
Learn more about the Institute for Cell Therapy Discovery & Innovation
The Institute for Data Science in Oncology (IDSO) integrates the tremendous power of meaningful data extraction and interpretation with UT MD Anderson’s unparalleled scientific and clinical expertise to transform research and care to impact patients.